A Phase 1 trial of CBT-101 in patients with PTPRZ1-MET Fusion Gene Positive Recurrent High-Grade Gliomas.
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Vebreltinib (Primary)
- Indications Cancer; Glioma
- Focus Adverse reactions
- 02 Sep 2016 New trial record